JP Morgan Chase
IBIO icon

JP Morgan Chase’s iBio IBIO Stock Holding History

JP Morgan Chase’s Portfolio IBIO Stock Details IBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3 Hold
2
– – ﹤0.01% 7466
2025
Q4 		$4 Hold
2
– – ﹤0.01% 7362
2025
Q3 		$2 Hold
2
– – ﹤0.01% 7347
2025
Q2 		$2 Hold
2
– – ﹤0.01% 7012
2025
Q1 		$8 Hold
2
– – ﹤0.01% 7199
2024
Q4 		$5 Hold
2
– – ﹤0.01% 7336
2024
Q3 		$4 Hold
2
– – ﹤0.01% 7334
2024
Q2 		$4 Hold
2
– – ﹤0.01% 7252
2024
Q1 		$8 Hold
2
– – ﹤0.01% 7250
2023
Q4 		$3 Sell
2
-1
-33% -$4 ﹤0.01% 7461
2023
Q3 		$15 Hold
3
– – ﹤0.01% 7228
2023
Q2 		$31 Hold
3
– – ﹤0.01% 6768
2023
Q1 		$0 Hold
3
– – ﹤0.01% 6950
2022
Q4 		$0 Hold
3
– – ﹤0.01% 6755
2022
Q3 		$0 Hold
3
– – ﹤0.01% 6633
2022
Q2 		$0 Sell
3
-202
-99% -$30.4K ﹤0.01% 6654
2022
Q1 		$44K Buy
205
+37
+22% +$7.74K ﹤0.01% 5845
2021
Q4 		$46K Hold
168
– – ﹤0.01% 5983
2021
Q3 		$90K Sell
168
-204
-55% -$127K ﹤0.01% 5624
2021
Q2 		$280K Sell
372
-809
-69% -$590K ﹤0.01% 5062
2021
Q1 		$909K Buy
1,181
+185
+19% +$161K ﹤0.01% 4300
2020
Q4 		$523K Buy
996
+749
+303% +$610K ﹤0.01% 4341
2020
Q3 		$258K Buy
247
+167
+209% +$242K ﹤0.01% 4249
2020
Q2 		$88K Buy
+80
New +$52.3K ﹤0.01% 4620

Other funds holding IBIO

AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

JP Morgan Chase's IBIO Position: Q1 2026 in Review

JP Morgan Chase held its iBio (IBIO) position steady in Q1 2026 at 2 shares worth $3. The position accounts for ﹤0.01% of the portfolio, ranked #7466.

JP Morgan Chase first reported a position in IBIO in Q2 2020 and has held it in 24 quarters since. The position peaked at $909K in Q1 2021. 52 funds tracked by Wall St. Rank hold IBIO as of Q1 2026.

  • JP Morgan Chase held 2 shares of iBio worth $3 as of Q1 2026.
  • JP Morgan Chase left its iBio share count unchanged in Q1 2026.
  • iBio made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #7466 holding.
  • JP Morgan Chase first reported a position in iBio in Q2 2020 and has held it in 24 quarters since.
  • JP Morgan Chase's iBio position peaked at $909K in Q1 2021.
  • 52 funds tracked by Wall St. Rank held iBio as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.